Rocket Pharmaceuticals
RCKT
RCKT
234 hedge funds and large institutions have $722M invested in Rocket Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 111 increasing their positions, 41 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.05% less ownership
Funds ownership: 103.1% → 101.05% (-2%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
48% less capital invested
Capital invested by funds: $1.38B → $722M (-$655M)
Holders
234
Holding in Top 10
2
Calls
$3.92M
Puts
$1.44M
Top Buyers
| 1 | +$9.72M | |
| 2 | +$6.67M | |
| 3 | +$6.24M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.2M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$3.99M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$18.4M | |
| 3 | -$17.4M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$15.1M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$13.2M |